Funding for this research was provided by:
Janssen Research and Development (NA)
Text and Data Mining valid from 2018-10-29
Received: 9 March 2018
Accepted: 2 October 2018
First Online: 29 October 2018
Ethics approval and consent to participate
: This was a secondary retrospective analysis based on data collected in STAR*D study, so the institutional review board approval and informed consent were not required. Patient identifiers are not disclosed and only summary data are presented. The study team obtained limited access STAR*D dataset, following the NIMH procedure for obtaining and analyzing the research data.
: Not applicable.
: AD, XL, QZ, JX, LL, CJ, CB, KL, GL are employees of Janssen Research & Development, LLC and hold stocks in the company. LB, PB, RB, and JR are in research collaboration with Janssen for which grant support has been received by Karolinska Institutet. JR has been a speaker for Eli Lilly, received unrestricted grant support from Schering-Plough, and has conducted research in collaboration with AstraZeneca, and Pfizer, for which grant/research support has been received by Karolinska Institutet.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.